Airway inflammation in aluminium potroom asthma

Occupational and Environmental Medicine

Volumn 61, Issue 9, 2004, Pages 779-785

  Sjaheim T ^a,b   Halstensen, T S ^b   Lund, M B ^b   Bjortuft O ^b   Drablos P A ^c   Malterud, D ^d   Kongerud, J ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c Health Department   (Norway)

^d Elkem Carbon AS   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM DERIVATIVE; FLUORESCENT DYE; NITRIC OXIDE;

ADULT; ARTICLE; ASTHMA; BRONCHUS BIOPSY; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; FLUORESCENCE HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LAMINA PROPRIA; LEUKOCYTE; LEUKOCYTE COUNT; MAST CELL; NEUTROPHIL; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SMOKING HABIT; STATISTICAL SIGNIFICANCE; THICKNESS; WORKER;

ADULT; ALUMINUM; ASTHMA; BASEMENT MEMBRANE; BIOPSY; BRONCHI; BRONCHITIS; EPITHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOCYTES; METALLURGY; MIDDLE AGED; OCCUPATIONAL EXPOSURE;

BRONCHUS;

EID: 4444340020     PISSN: 13510711     EISSN: None     Source Type: Journal    
DOI: 10.1136/oem.2003.011627     Document Type: Article

References (45)

1. Abromson MJ, Wlodarczyk JH, Saunders NA, et al. Does aluminium smelting cause lung disease? Am Rev Respir Dis 1989;139:1042-57.
2. Kongerud J, Gronnesby JK, Magnus P. Respiratory symptoms and lung function of aluminium potroom workers. Scand J Work Environ Health 1990;16:270-7.
3. Kongerud J, Samuelsen SO. A longitudinal study of respiratory symptoms in aluminium potroom workers. Am Rev Respir Dis 1991;144:10-16.
4. Kongerud J, Soyseth V, Burge S. Serial measurements of peak expiratory flow and responsiveness to methacholine in the diagnosis of aluminium potroom asthma. Thorax 1992;47:292-7.
5. Desjardins A, Bergeron JP, Ghezzo H, et al. Aluminium potroom asthma confirmed by monitoring of forced expiratory volume in one second. Am J Respir Crit Care Med 1994;150:1714-17.
6. Sayseth V, Kongerud J. Prevalence of respiratory disorders among aluminium potroom workers in relation to exposure to fluoride. Br J Ind Med 1992;49:125-30.
7. Steinegger AF, Schlatter C. Evaluation of fluoride exposure in aluminium smelters: state of the art. Med Lav 1992;83:489-98.
8. Saric M, Zuskin E, Gomzi M. Bronchoconstriction in potroom workers. Br J Ind Med 1979;36:211-15.
9. Chan-Yeung M, Lam S. Occupational asthma. Am Rev Respir Dis 1986;133:686-703.
10. Midttun O. Bronchial asthma in the aluminium industry. Acta Allergol 1960;15:208-21.
11. Sorgdrager B, Pal TM, de Looff AJ, et al. Occupational asthma in aluminium potroom workers related to pre-employment eosinophil count. Eur Respir J 1995;8:1520-4.
12. Sayseth V, Kongerud J, Ekstrand J, et al. Relation between exposure to fluoride and bronchial responsiveness in aluminium potroom workers with work-related asthma-like symptoms. Thorax 1994;49:984-9.
13. Soyseth V, Kongerud J, Aalen OO, et al. Bronchial responsiveness decreases in relocated aluminium potroom workers compared with workers who continue their potroom exposure. Int Arch Occup Environ Health 1995;67:53-7.
14. Kongerud J, Soyseth V. Methacholine responsiveness, respiratory symptoms and pulmonary function in aluminium potroom workers. Eur Respir J 1991;4:159-66.
15. Lund K, Refsnes M, Sandstrom T, et al. Increased CD3 positive cells in bronchoalveolar lavage fluid after hydrogen fluoride inhalation. Scand J Work Environ Health 1999;25:326-34.
16. Lund MB, Oksne PI, Hamre R, et al. Increased nitric oxide in exhaled air: an early marker of asthma in non-smoking aluminium potroom workers? Occup Environ Med 2000;57:274-8.
17. Anon. International consensus report on diagnosis and treatment of asthma. National Heart, Lung, and Blood Institute, National Institutes of Health. Bethesda, Maryland 20892. Publication no. 92-3091, March 1992. Eur Respir J 1992;5:601-41.
18. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:5-40.
19. Anon. Investigative use of bronchoscopy, lavage and bronchial biopsies in asthma and other airways diseases. Workshop summary and guidelines. Eur Respir J 1992;5:115-21.
20. Jahnsen FL, Haraldsen G, Rugtveit J, et al. Differential interference contrast microscopy combined with immunofluorescence: a new method to phenotype eosinophils in situ. J Immunol Methods 1994;173:77-91.
21. Sullivan P, Stephens D, Ansari T, et al. Variation in the measurements of basement membrane thickness and inflammatory cell number in bronchial biopsies. Eur Respir J 1998;12:811-15.
22. Saetta M, Di Stefano A, Maestrelli P, et al. Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate. Am Rev Respir Dis 1992;145:160-8.
23. Frew AJ, Chan H, Lam S, et al. Bronchial inflammation in occupational asthma due to western red cedar. Am J Respir Crit Care Med 1995;151:340-4.
24. Busse WW, Lemanske RF, Jr Asthma. N Engl J Med 2001;344:350-62.
25. Kharifonov SA, Yates D, Robbins RA, et al. Increased nitric oxide in exhaled air af asthmatic patients. Lancet 1994;343:133-5.
26. Wenzel SE, Schwartz LB, Langmack EL, et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999;160:1001-8.
27. Douwes J, Gibson P, Pekkanen J, et al. Non-eosinophilic asthma: importance and possible mechanisms. Thorax 2002;57:643-8.
28. Anees W, Huggins V, Pavord ID, et al. Occupational asthma due to low molecular weight agents: eosinophilic and non-eosinophilic variants. Thorax 2002;57:231-6.
29. Gibson PG, Simpson JL, Saltos N. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 2001;119:1329-36.
30. Pork HS, Hwang SC, Nahm DH, et al. Immunohistochemical characterization of the cellular infiltrate in airway mucosa of toluene diisocyanate (TDI)-induced asthma: comparison with allergic asthma. Journal of Korean Medical Science 1998;13:21-6.
31. Park HS, Jung KS, Hwang SC, et al. Neutrophil infiltration and release of IL-8 in airway mucosa from subjects with grain dust-induced occupational asthma. Clin Exp Allergy 1998;28:724-30.
32. Djukanovi R, Wilson JW, Britten KM, et al. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis 1990;142:863-71.
33. Di Stefano A, Saetta M, Maestrelli P, et al. Mast cells in the airway mucosa and rapid development of occupational asthma induced by toluene diisocyanate. Am Rev Respir Dis 1993;147:1005-9.
34. Saetta M, Maestrelli P, Di Stefano A, et al. Effect of cessation of exposure to toluene diisocyanate (TDI) on bronchial mucosa of subjects with TDI-induced asthma. Am Rev Respir Dis 1992;145:169-74.
35. Jeffery PK. Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crif Care Med 2001;164:S28-38.
36. Boulet LP, Laviolette M, Turcotte H, et al. Bronchial subepithelial fibrosis correlates with airway responsiveness to methacholine. Chest 1997;112:45-52.
37. Ordonez C, Ferrando R, Hyde DM, et al. Epithelial desquamation in asthma: artifact or pathology? Am J Respir Crit Care Med 2000;162:2324-9.
38. Wilson JW, Li X. The measurement of reticular basement membrane and submucosal collagen in the asthmatic airway. Clin Exp Allergy 1997;27:363-71.
39. Van Den Toorn LM, Overbeek SE, De Jongste JC, et al. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 2001;164:2107-13.
40. Sunyer J, Springer G, Jamieson B, et al. Effects of asthma on cell components in peripheral blood among smokers and non-smokers. Clin Exp Allergy 2003;33:1500-5.
41. Chalmers GW, MacLeod KJ, Thomson L, et al. Smoking and airway inflammation in patients with mild asthma. Chest 2001;120:1917-22.
42. Amin K, Ekeberg-Jansson A, Løfdahl C, et al. Relationship between inflammatory cells and structural changes in the lungs of asymptomatic and never smokers: a biopsy study. Thorax 2003;58:135-42.
43. Holt PG. Immune and inflammatory function in cigarette smokers. Thorax 1987;42:241-9.
44. Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003;421:384-8.
45. Robbins CS, Dawe DE, Goncharova SI, et al. Cigarette smoke decreases pulmonary dendritic cells and impacts antiviral immune responsiveness. Am J Respir Cell Mol Biol 2004;30:202-11.